LTRN
USDLantern Pharma Inc. Common Stock
$3.590-0.110 (-2.973%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Key Metrics
Market Metrics
Open
$3.700
High
$3.700
Low
$3.550
Volume
0.00M
Company Fundamentals
Market Cap
39.0M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.05M
Exchange
NCM
Currency
USD
52-Week Range
Low $2.55Current $3.590High $7.21
Related News
Analyst Upgrades
Lake Street Initiates Coverage On Lantern Pharma with Buy Rating, Announces Price Target of $25
Lake Street analyst Chad Messer initiates coverage on Lantern Pharma with a Buy rating and announces Price Target of $25.
View more
BusinessWire
Lantern Pharma Provides Business Updates and Fourth Quarter & Year-End 2024 Financial Results
HARMONIC™ trial lead-in cohort delivered impressive 86% clinical benefit rate and 43% objective response rate in never-smoker NSCLC patients, with current expansion cohort reinforcing these positive trends as
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.